本页面由Tiger Trade Technology Pte. Ltd.提供服务

Propanc Biopharma, Inc.

0.2779
-0.1121-28.74%
盘前0.2650-0.0129-4.64%06:19 EST
成交量:190.43万
成交额:56.34万
市值:371.39万
市盈率:-0.06
高:0.3495
开:0.3401
低:0.2570
收:0.3900
52周最高:11.00
52周最低:0.0002
股本:1,336.42万
流通股本:340.45万
量比:1.55
换手率:55.93%
股息:- -
股息率:- -
每股收益(TTM):-4.9510
每股收益(LYR):-14.8490
净资产收益率:-1236.83%
总资产收益率:-427.27%
市净率:0.26
市盈率(LYR):-0.02

数据加载中...

2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/30

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/04/21

重要事件披露

Form 8-K - Current report
2025/04/08

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/04/02

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/03/31

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/03/18

重要事件披露

Form 8-K - Current report
2025/02/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/02/12

重要事件披露

Form 8-K - Current report
2024/12/20

重要事件披露

Form 8-K - Current report
2024/12/06

重要事件披露

Form 8-K - Current report
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/30

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/09/30

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/09/27

重要事件披露

Form 8-K - Current report
2024/08/30

重要事件披露

Form 8-K - Current report